Ado S, Dong C, Attaf N, Moussa M, Carrier A, Milpied P
Front Immunol. 2025; 15:1505971.
PMID: 39742275
PMC: 11685048.
DOI: 10.3389/fimmu.2024.1505971.
Lopatto E, Santiago-Borges J, Sanick D, Malladi S, Azimzadeh P, Timm M
bioRxiv. 2024; .
PMID: 39713358
PMC: 11661314.
DOI: 10.1101/2024.12.10.627638.
Yoshizato R, Miura M, Shitaoka K, Matsuoka Y, Higashiura A, Yamamoto A
Heliyon. 2024; 10(23):e40837.
PMID: 39698082
PMC: 11652855.
DOI: 10.1016/j.heliyon.2024.e40837.
Ende Z, Mishina M, Kauffman R, Kumar A, Kumari R, Knight P
J Immunol Methods. 2024; 534:113768.
PMID: 39447635
PMC: 11585411.
DOI: 10.1016/j.jim.2024.113768.
Fu M, Wang X, Tang S, Bai S, Ding L, Hu Y
STAR Protoc. 2024; 5(4):103389.
PMID: 39396232
PMC: 11735987.
DOI: 10.1016/j.xpro.2024.103389.
Advancements in mammalian display technology for therapeutic antibody development and beyond: current landscape, challenges, and future prospects.
Slavny P, Hegde M, Doerner A, Parthiban K, McCafferty J, Zielonka S
Front Immunol. 2024; 15:1469329.
PMID: 39381002
PMC: 11459229.
DOI: 10.3389/fimmu.2024.1469329.
Repeat modules and N-linked glycans define structure and antigenicity of a critical enterotoxigenic E. coli adhesin.
Berndsen Z, Akhtar M, Thapa M, Vickers T, Schmitz A, Torres J
PLoS Pathog. 2024; 20(9):e1012241.
PMID: 39283948
PMC: 11463764.
DOI: 10.1371/journal.ppat.1012241.
An attachment glycoprotein nanoparticle elicits broadly neutralizing antibodies and protects against lethal Nipah virus infection.
Zhou D, Cheng R, Yao Y, Zhang G, Li X, Wang B
NPJ Vaccines. 2024; 9(1):158.
PMID: 39217188
PMC: 11365981.
DOI: 10.1038/s41541-024-00954-5.
Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding site.
Caniels T, Medina-Ramirez M, Zhang S, Kratochvil S, Xian Y, Koo J
Sci Immunol. 2024; 9(98):eadk9550.
PMID: 39213338
PMC: 11783328.
DOI: 10.1126/sciimmunol.adk9550.
A broadly protective antibody targeting glycoprotein Gn inhibits severe fever with thrombocytopenia syndrome virus infection.
Ren X, Sun J, Kuang W, Yu F, Wang B, Wang Y
Nat Commun. 2024; 15(1):7009.
PMID: 39147753
PMC: 11327358.
DOI: 10.1038/s41467-024-51108-z.
Peripheral apoptosis and limited clonal deletion during physiologic murine B lymphocyte development.
Simpson M, Newen A, McNees C, Sharma S, Pfannenstiel D, Moyer T
Nat Commun. 2024; 15(1):4691.
PMID: 38824171
PMC: 11144239.
DOI: 10.1038/s41467-024-49062-x.
Repeat modules and N-linked glycans define structure and antigenicity of a critical enterotoxigenic .
Berndsen Z, Akhtar M, Thapa M, Vickers T, Schmitz A, Torres J
bioRxiv. 2024; .
PMID: 38766097
PMC: 11100705.
DOI: 10.1101/2024.05.08.593125.
mRNA-LNP prime boost evolves precursors toward VRC01-like broadly neutralizing antibodies in preclinical humanized mouse models.
Wang X, Cottrell C, Hu X, Ray R, Bottermann M, Villavicencio P
Sci Immunol. 2024; 9(95):eadn0622.
PMID: 38753808
PMC: 11488661.
DOI: 10.1126/sciimmunol.adn0622.
mRNA-LNP HIV-1 trimer boosters elicit precursors to broad neutralizing antibodies.
Xie Z, Lin Y, Steichen J, Ozorowski G, Kratochvil S, Ray R
Science. 2024; 384(6697):eadk0582.
PMID: 38753770
PMC: 11488660.
DOI: 10.1126/science.adk0582.
A portable transistor immunosensor for fast identification of porcine epidemic diarrhea virus.
Hu X, Zhang M, Liu Y, Li Y, Li W, Li T
J Nanobiotechnology. 2024; 22(1):239.
PMID: 38735951
PMC: 11089749.
DOI: 10.1186/s12951-024-02440-5.
Eliciting a single amino acid change by vaccination generates antibody protection against group 1 and group 2 influenza A viruses.
Ray R, Nait Mohamed F, Maurer D, Huang J, Alpay B, Ronsard L
Immunity. 2024; 57(5):1141-1159.e11.
PMID: 38670113
PMC: 11096021.
DOI: 10.1016/j.immuni.2024.03.022.
Heterologous Booster Immunization Based on Inactivated SARS-CoV-2 Vaccine Enhances Humoral Immunity and Promotes BCR Repertoire Development.
Li X, Zeng F, Yue R, Ma D, Meng Z, Li Q
Vaccines (Basel). 2024; 12(2).
PMID: 38400104
PMC: 10891849.
DOI: 10.3390/vaccines12020120.
Extraction of the CDRH3 sequence of the mouse antibody repertoire selected upon influenza virus infection by subtraction of the background antibody repertoire.
Shingai M, Iida S, Kawai N, Kawahara M, Sekiya T, Ohno M
J Virol. 2024; 98(3):e0199523.
PMID: 38323813
PMC: 10949447.
DOI: 10.1128/jvi.01995-23.
Antibodies from dengue patients with prior exposure to Japanese encephalitis virus are broadly neutralizing against Zika virus.
Salem G, Galula J, Wu S, Liu J, Chen Y, Wang W
Commun Biol. 2024; 7(1):15.
PMID: 38267569
PMC: 10808242.
DOI: 10.1038/s42003-023-05661-w.
The Research Progress on Immortalization of Human B Cells.
Xu H, Xiang X, Ding W, Dong W, Hu Y
Microorganisms. 2023; 11(12).
PMID: 38138080
PMC: 10746006.
DOI: 10.3390/microorganisms11122936.